Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 30 of the 32 references it cites were found in a registry or an index; 1 of the 13 sources its claims cite were checked for support.

Self-managed, computerised speech and language therapy for patients with chronic aphasia post-stroke compared with usual care or attention control (Big CACTUS): a multicentre, single-blinded, randomised controlled trial

Open access

Abstract

BACKGROUND: Post-stroke aphasia might improve over many years with speech and language therapy; however speech and language therapy is often less readily available beyond a few months after stroke. We assessed self-managed computerised speech and language therapy (CSLT) as a means of providing more therapy than patients can access through usual care alone. METHODS: In this pragmatic, superiority, three-arm, individually randomised, single-blind, parallel group trial, patients were recruited from 21 speech and language therapy departments in the UK. Participants were aged 18 years or older and had been diagnosed with aphasia post-stroke at least 4 months before randomisation; they were excluded if they had another premorbid speech and language disorder caused by a neurological deficit other than stroke, required treatment in a language other than English, or if they were currently using computer-based word-finding speech therapy. Participants were randomly assigned (1:1:1) to either 6 months of usual care (usual care group), daily self-managed CSLT plus usual care (CSLT group), or attention control plus usual care (attention control group) with the use of computer-generated stratified blocked randomisation (randomly ordered blocks of sizes three and six, stratified by site and severity of word finding at baseline based on CAT Naming Objects test scores). Only the outcome assessors and trial statistician were masked to the treatment allocation. The speech and language therapists who were doing the outcome assessments were different from those informing participants about which group they were assigned to and from those delivering all interventions. The statistician responsible for generating the randomisation schedule was separate from those doing the analysis. Co-primary outcomes were the change in ability to retrieve personally relevant words in a picture naming test (with 10% mean difference in change considered a priori as clinically meaningful) and the change in functional communication ability measured by masked ratings of video-recorded conversations, with the use of Therapy Outcome Measures (TOMs), between baseline and 6 months after randomisation (with a standardised mean difference in change of 0·45 considered a priori as clinically meaningful). Primary analysis was based on the modified intention-to-treat (mITT) population, which included randomly assigned patients who gave informed consent and excluded those without 6-month outcome measures. Safety analysis included all participants. This trial has been completed and was registered with the ISRCTN, number ISRCTN68798818. FINDINGS: From Oct 20, 2014, to Aug 18, 2016, 818 patients were assessed for eligibility, of which 278 (34%) participants were randomly assigned (101 [36%] to the usual care group; 97 [35%] to the CSLT group; 80 [29%] to the attention control group). 86 patients in the usual care group, 83 in the CSLT group, and 71 in the attention control group contributed to the mITT. Mean word finding improvements were 1·1% (SD 11·2) in the usual care group, 16·4% (15·3) in the CSLT group, and 2·4% (8·8) in the attention control group. Word finding improvement was 16·2% (95% CI 12·7 to 19·6; p<0·0001) higher in the CSLT group than in the usual care group and was 14·4% (10·8 to 18·1) higher than in the attention control group. Mean changes in TOMs were 0·05 (SD 0·59) in the usual care group (n=84), 0·04 (0·58) in the CSLT group (n=81), and 0·10 (0·61) in the attention control group (n=68); the mean difference in change between the CSLT and usual care groups was -0·03 (-0·21 to 0·14; p=0·709) and between the CSLT and attention control groups was -0·01 (-0·20 to 0·18). The incidence of serious adverse events per year were rare with 0·23 events in the usual care group, 0·11 in the CSLT group, and 0·16 in the attention control group. 40 (89%) of 45 serious adverse events were unrelated to trial activity and the remaining five (11%) of 45 serious adverse events were classified as unlikely to be related to trial activity. INTERPRETATION: CSLT plus usual care resulted in a clinically significant improvement in personally relevant word finding but did not result in an improvement in conversation. Future studies should explore ways to generalise new vocabulary to conversation for patients with chronic aphasia post-stroke. FUNDING: National Institute for Health Research, Tavistock Trust for Aphasia.

Overview

CoChat Summary

TL;DR

In the Big CACTUS multicentre randomised trial, self-managed computerised speech and language therapy (CSLT) plus usual care improved personally relevant word finding in chronic post-stroke aphasia compared with usual care or attention control, but did not improve functional communication in conversation. CSLT was low-cost and safe, with cost-effectiveness more likely for mild or moderate word-finding difficulties than for the whole aphasia population.

Key findings

  • Among 240 participants in the modified intention-to-treat analysis, mean word-finding improvement was 1·1% (SD 11·2) with usual care, 16·4% (15·3) with CSLT, and 2·4% (8·8) with attention control. CSLT improved word finding by 16·2% (95% CI 12·7–19·6; p<0·0001) versus usual care and 14·4% (10·8–18·1) versus attention control, exceeding the prespecified 10% clinically important difference; improvement was maintained at 9 and 12 months.
  • Functional communication on TOMs did not improve: mean changes were 0·05 (SD 0·59) with usual care, 0·04 (0·58) with CSLT, and 0·10 (0·61) with attention control; CSLT vs usual care adjusted mean difference was –0·03 (–0·21 to 0·14; p=0·709) and CSLT vs attention control was –0·01 (–0·20 to 0·18).
  • The key secondary COAST outcome did not show sufficient improvement: CSLT vs usual care 0·5 (–3·1 to 4·1; p=0·772); CSLT vs attention control 3·8 (0·0 to 7·5; p=0·051).
  • Safety events were rare: serious adverse event incidence per year was 0·23 in usual care, 0·11 in CSLT, and 0·16 in attention control; 40 (89%) of 45 serious adverse events were unrelated to trial activity and five (11%) were unlikely to be related. In the CSLT group, 23 (27%) of 85 participants reported fatigue or anxiety at some point during 6 months of computer use.
  • Health economic results: incremental cost of CSLT was £733 (95% credible interval 674–798), incremental QALY gain was 0·017 (–0·05 to 0·10), and ICER was £42,686 per QALY gained versus usual care and £40,164 versus attention control; ICERs were £22,371 for mild and £28,819 for moderate word-finding difficulty, while CSLT was more expensive and produced fewer QALYs than usual care for severe word-finding difficulties.

Methods

  • Pragmatic, superiority, three-arm, individually randomised, single-blind, parallel group trial recruiting from 21 speech and language therapy departments in the UK. Participants were aged ≥18 years with aphasia confirmed after stroke at least 4 months before randomisation, word-finding difficulties (CAT Naming Objects score 5–43/48), and ability to perform StepByStep matching and repetition tasks at ≥50% accuracy; exclusions included other premorbid speech/language disorder, need for treatment in a language other than English, or current computer-based word-finding therapy.
  • Participants were randomly assigned 1:1:1 to 6 months of usual care, CSLT plus usual care, or attention control plus usual care, using stratified block randomisation by site and baseline word-finding severity. Outcome assessors and the trial statistician were masked; treating therapists and participants were not.
  • Co-primary outcomes were change from baseline to 6 months in a picture naming test of 100 personally relevant words and in functional communication measured by masked TOMs activity ratings of video-recorded conversations. Primary analysis used the modified intention-to-treat population, multiple linear regression adjusted for baseline outcome and stratification factors, and a Hochberg multiple testing procedure; safety analysis included all participants.

Limitations

  • The paper states that only one computer program and one language domain (word finding) were tested; the software was English-only, so patients requiring another language were excluded; participant ethnicity was not recorded; and further research is needed to identify patient characteristics, motivation, dose response, and effects of continued practice.
  • The paper also notes that recruitment stopped after 278 of 285 planned participants, with chance imbalance across groups; TOMs may not detect small changes; the trial was not powered to detect a meaningful QALY difference; and attention control activity with puzzle books could not be measured as accurately as computer practice.
  • Evident from the text: the attention control group was smaller and had some baseline differences, including a greater proportion with severe comprehension difficulties and lower baseline TOMs scores, which the authors note may have affected power and comparisons.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1016/s1474-4422(19)30192-9

Cites

30 of 30 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Figure 1 Trial profile CSLT=computerised speech language therapy. *Deaths before 6 months excluded in all clinical effectiveness analysis but included in safety analysis. † Participants included in the modified intention-to-treat primary analysis set.
Figure 1 Trial profile CSLT=computerised speech language therapy. *Deaths before 6 months excluded in all clinical effectiveness analysis but included in safety analysis. † Participants included in the modified intention-to-treat primary analysis set.CC BY · PubMed Central
Figure 2 Mean response profile of participants for the co-primary and key secondary outcomes COAST=Communication Outcomes After Stroke. CSLT=computerised speech language therapy. TOMs=Therapy Outcome Measures.
Figure 2 Mean response profile of participants for the co-primary and key secondary outcomes COAST=Communication Outcomes After Stroke. CSLT=computerised speech language therapy. TOMs=Therapy Outcome Measures.CC BY · PubMed Central

Verification

Claims the paper makes

1 Valid · 0 Not valid · 10 Not checked · 96 Own results and interpretations

47 more claims

Create a free account to see all 107 claims and to verify the 1 reference still open.

See all claims — free account
  • It may state two separate claims as one. 36
  • Probably not a substantial claim. 27
  • The quote only partly states this claim. 1

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

14 more claims about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

2 of 2

Citations

Cites

Show all 32 references

Cited by

See all 200

Metadata

Authors
Palmer, R., Dimairo, M., Cooper, C., Enderby, P., Brady, M., Bowen, A., Latimer, N., Julious, S., Cross, E., Alshreef, A., Harrison, M., Bradley, E., Witts, H., & Chater, T.
Affiliations
  • University of Sheffield (GB)
  • Glasgow Caledonian University (GB)
  • Manchester Academic Health Science Centre (GB)
  • Derbyshire Community Health Services NHS Foundation Trust (GB)
Corresponding author
Cooper, Cindy
Venue
The Lancet Neurology
Publisher
Elsevier BV
Published
2019-09
Volume
18
Issue
9
Pages
821-833
ISSN
1474-4422 (ISSN-L)
OpenAlex
W2950366686
Cited by
200
References
32
Citations by year
2026: 23 · 2025: 37 · 2024: 27 · 2023: 23 · 2022: 35 · 2021: 26 · 2020: 25 · 2019: 3
FWCI
12.93
Type
journal article
Language
en
Open access
Licence
Locations
  • The Lancet Neurology (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • White Rose Research Online (University of Leeds, The University of Sheffield, University of York) (acceptedVersion)
  • ResearchOnline (Glasgow Caledonian University) (acceptedVersion, cc-by)
  • Research Explorer (The University of Manchester) (submittedVersion, other-oa)
Funders
  • National Institute for Health Research
  • Stroke Association
  • Collaboration for Leadership in Applied Health Research and Care - Greater Manchester
  • Yorkshire Cancer Research (S406NL)
  • Higher Education Funding Council for England
  • Health Technology Assessment Programme (12/21/01)
Topics
  • Life Sciences › Neuroscience › Cognitive Neuroscience › Neurobiology of Language and Bilingualism
  • Health Sciences › Medicine › Rehabilitation › Stroke Rehabilitation and Recovery
  • Health Sciences › Health Professions › Occupational Therapy › Assistive Technology in Communication and Mobility
Keywords
post-stroke aphasia, word retrieval, picture naming, functional communication, usual care, attentional control, stroke rehabilitation, pragmatic competence
MeSH terms
Stroke Rehabilitation, Adult, Aged, Aged, 80 and over, Aphasia, Attention, Female, Humans, Language Therapy, Male, Middle Aged, Speech Therapy, Single-Blind Method, Treatment Outcome, Stroke, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Self-managed, computerised speech and language therapy for patients with chronic aphasia post-stroke compared with usual care or attention control (Big CACTUS): a multicentre, single-blinded, randomised controlled trial. https://app.cochat.ai/papers/10.1016/s1474-4422(19)30192-9
The paper
Palmer, R., Dimairo, M., Cooper, C., Enderby, P., Brady, M., Bowen, A., Latimer, N., Julious, S., Cross, E., Alshreef, A., Harrison, M., Bradley, E., Witts, H., & Chater, T. (2019). Self-managed, computerised speech and language therapy for patients with chronic aphasia post-stroke compared with usual care or attention control (Big CACTUS): a multicentre, single-blinded, randomised controlled trial. The Lancet Neurology. https://doi.org/10.1016/s1474-4422(19)30192-9

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.